Eli Lilly
07:05 :
Eli Lilly net income falls 27% as patents expire -
MADRID (MarketWatch) -- Eli Lilly & Co. on Tuesday reported a fourth-quarter net income fall of 27% on a sales decline of 2% as patents expired on its Zyprexa and Gemzar drugs. Net income fell to $858.2 million, or 77 cents per share, ...
15:25 :
Forbes Earnings Preview: Eli Lilly -
Analysts expect decreased profit for Eli Lilly (LLY) when the company reports its fourth quarter results on Tuesday, January 31, 2012. Although Eli Lilly reported profit of $1.11 a year ago, the consensus estimate calls ...
14:06 :
Jubilant Life Buys Out Eli Lilly Stake In JV -
Jubilant Life Sciences Ltd. (530019.BY) has bought out U.S.-based Eli Lilly & Co.'s (LLY) stake in a 50-50 joint venture the two companies formed in 2008 to provide outsourced early-stage drug development services, its executive director ...
09:12 :
Eli Lilly 2012 profit forecast misses expectations -
INDIANAPOLIS (AP) -- Eli Lilly and Co. forecasts a steeper-than-expected earnings drop this year due to the expiration of a patent protecting its top-selling drug, the antipsychotic Zyprexa....
15:45 :
Eli Lilly & Co. Shares Cross 5% Yield Mark -
Looking at the universe of stocks we cover at Dividend Channel, in trading on Thursday, shares of Eli Lilly & Co. (NYSE: LLY) were yielding above the 5% mark based on its quarterly dividend (annualized to $1.96), with the stock changing ...
12:10 :
Eli Lilly faces tough times with patent losses -
HONOLULU (Reuters) - Eli Lilly and Co has hit a tough spot with the pharmaceutical company's top treatment now facing competition from cheaper generic brands and the looming loss of patent protection...
11:05 :
Eli Lilly & Co. To Trade Ex-Dividend -
Looking at the universe of stocks we cover at Dividend Channel, on 11/10/11, Eli Lilly & Co. (NYSE: LLY) will trade ex-dividend, for its quarterly dividend of $0.49, payable on 12/9/11. As a percentage of LLY's recent stock price of $38.67, ...
06:15 :
Eli Lilly Q3 net profit drops 5%; sales rise 9% -
LONDON (MarketWatch) -- Eli Lilly and Co. said Thursday its third-quarter net profit fell to $1.24 billion, or $1.11 a share, from $1.30 billion, or $1.18 a share, in the same period a year ago. Revenue rose 9% to $6.15 billion. Adjusted ...
16:06 :
Eli Lilly & Co. Shares Cross 5% Yield Mark -
According to Dividend Channel, in trading on Friday, shares of Eli Lilly & Co. (LLY) were yielding above the 5% mark based on its quarterly dividend (annualized to $1.96), with the stock changing hands as low as $38.62 on the day. Dividends ...
06:54 :
Eli Lilly 2Q profit falls 11 percent -
INDIANAPOLIS (AP) -- Eli Lilly and Co. said Thursday its second-quarter net income fell 11 percent, as increases in marketing and other expenses blunted the drugmaker's revenue growth....
06:22 :
Eli Lilly second-quarter earnings fall 11% -
FRANKFURT (MarketWatch) -- Eli Lilly & Co. on Thursday said second-quarter net income fell to $1.20 billion, or $1.07 a share, versus $1.35 billion, or $1.22 a share, in the same period the previous year. Adjusted earnings declined to ...
06:28 :
Eli Lilly outlines financials, has 70 drugs in R&D -
TEL AVIV (MarketWatch) -- Eli Lilly & Co., the Indianapolis health-care firm, said on Thursday that consistent with its estimates, it expects to post at least $3 billion of net income and at least $20 billion of revenue a year from 2011 ...
actualidad Eli Lilly -